Despite accounting for half the population, women's health receives only a fraction of healthcare funding, leading to delayed diagnoses and significant productivity loss. At the same time, the market is rapidly maturing: Europe is approaching a €13 billion opportunity, with strong growth in FemTech and AI-driven diagnostics addressing long-overlooked conditions. This structural gap, combined with accelerating innovation, positions women's health as one of the most relevant investment themes today.
An in-depth analysis of this opportunity was written by Simone Brummelhuis and Annemarie Haverhals in Financial Investigator: Read the article.